🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
This study is a multicenter, prospective, randomized phase II trial aimed a...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2024-03-01
Trial ID
NCT06272214
Treatments Being Tested
This phase I trial studies the side effects and best dose of stereotactic b...
Status
Completed
Location
University of Wisconsin Carbone Cancer Center
Start Date
2014-04-08
Trial ID
NCT01918644
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
The study proposes to assess the effect of multiple applications of antimic...
Status
Completed
Location
Mariana Sales
Start Date
2014-09-01
Trial ID
NCT03039244
Treatments Being Tested
The aim of this study is to investigate the feasibility of sentinel node bi...
Status
Completed
Location
Karolinska University Hospital
Start Date
2019-12-14
Trial ID
NCT04147780
Treatments Being Tested
This open-label, multicenter, randomized phase II study will evaluate the u...
Status
Active Not Recruiting
Location
BC Cancer, Vancouver Centre
Start Date
2019-03-19
Trial ID
NCT03769103
Treatments Being Tested
The current trial is evaluating the integration of a pretherapeutical FDG-P...
Status
Completed
Location
University Hospital Tübingen, Department of Radiation Oncology
Start Date
2015-07
Trial ID
NCT02666885
Treatments Being Tested
This multi-institutional, phase 2 clinical trial is studying two doses of p...
Status
Completed
Location
Mayo Clinic
Start Date
2017-01
Trial ID
NCT02818920
Treatments Being Tested
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817